Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Goodwin

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Current Oncology (Toronto, Ont.)|August 25, 2023
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in CanadaRavi Ramjeesingh, Prosanto Chaudhury, Vincent C Tam, et al.
The Oncologist|August 18, 2019
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229)Stephen Chia, Phillipe L Bedard, John Hilton, et al.
Investigational New Drugs|September 12, 2019
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancerRachel Goodwin, Derek Jonker, Eric Chen, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer CentresGautham Nair, Morgan Black, Kathie Baer, et al.
The American Journal of Cardiology|June 6, 2018
Prognostic Value of Anatomical SYNTAX Score and SYNTAX Score II in Veterans With Left Main and/or Three-Vessel Coronary Artery DiseaseNaoki Misumida, Ahmed Elsharawy Ahmed, Mariah Barlow, et al.
Health Science Reports|December 23, 2021
Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trialArif Awan, Bassam Basulaiman, Carol Stober, et al.
Cancer Treatment Reviews|May 30, 2016
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensusSimron Singh, Sylvia L Asa, Chris Dey, et al.
Clinical Colorectal Cancer|March 12, 2016
PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer ConsortiumDominick Bossé, Jamison Mercer, Soundouss Raissouni, et al.
Clinical Colorectal Cancer|October 5, 2015
Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter StudyDawn Armstrong, Soundouss Raissouni, Julie Price Hiller, et al.
Breast Cancer Research : BCR|May 4, 2017
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancerStephen K Chia, Susan L Ellard, Mihaela Mates, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Current Oncology (Toronto, Ont.)|August 25, 2023
A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in CanadaRavi Ramjeesingh, Prosanto Chaudhury, Vincent C Tam, et al.
The Oncologist|August 18, 2019
A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229)Stephen Chia, Phillipe L Bedard, John Hilton, et al.
Investigational New Drugs|September 12, 2019
A phase Ib study of a PI3Kinase inhibitor BKM120 in combination with panitumumab in patients with KRAS wild-type advanced colorectal cancerRachel Goodwin, Derek Jonker, Eric Chen, et al.
Current Oncology (Toronto, Ont.)|February 25, 2025
Treatment Patterns of Pancreatic Neuroendocrine Tumor (pNET) Patients at Two Canadian Cancer CentresGautham Nair, Morgan Black, Kathie Baer, et al.
The American Journal of Cardiology|June 6, 2018
Prognostic Value of Anatomical SYNTAX Score and SYNTAX Score II in Veterans With Left Main and/or Three-Vessel Coronary Artery DiseaseNaoki Misumida, Ahmed Elsharawy Ahmed, Mariah Barlow, et al.
Health Science Reports|December 23, 2021
Oral magnesium supplements for cancer treatment-induced hypomagnesemia: Results from a pilot randomized trialArif Awan, Bassam Basulaiman, Carol Stober, et al.
Cancer Treatment Reviews|May 30, 2016
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensusSimron Singh, Sylvia L Asa, Chris Dey, et al.
Clinical Colorectal Cancer|March 12, 2016
PROSPECT Eligibility and Clinical Outcomes: Results From the Pan-Canadian Rectal Cancer ConsortiumDominick Bossé, Jamison Mercer, Soundouss Raissouni, et al.
Clinical Colorectal Cancer|October 5, 2015
Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter StudyDawn Armstrong, Soundouss Raissouni, Julie Price Hiller, et al.
Breast Cancer Research : BCR|May 4, 2017
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancerStephen K Chia, Susan L Ellard, Mihaela Mates, et al.
Pageof 5